Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

7.67p
   
  • Change Today:
    -0.083p
  • 52 Week High: 50.40
  • 52 Week Low: 7.50
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 147,902
  • Market Cap: £14.56m
  • RiskGrade: 348
  • Beta: 1.46

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1293.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 8.2 n/a
Pr/Book n/a  
Latest F'cast
Revenue -32.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 n/a (10.61) (16.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-21 1.49 (35.79) (43.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-22 2.97 (49.63) (78.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-23 3.40 (45.60) (55.00)p n/a n/a n/a n/a 0.0%
30-Jun-24 2.29 (33.45) (31.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

Financial Results for Q1 of Fiscal Year 2025 20-Nov-2024 07:00 RNS
Holding(s) in Company 08-Nov-2024 09:31 RNS
Holding(s) in Company 07-Nov-2024 16:35 RNS

RENX ShareCast News

Renalytix terminates formal sale process 20-Aug-2024 ShareCast
Renalytix test gets US Medicare coverage determi... 14-Jun-2024 ShareCast
Renalytix surges on takeover approach 04-Mar-2024 ShareCast

Latest RENX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 7.67p
Change Today -0.083p
% Change -1.08 %
52 Week High 50.40
52 Week Low 7.50
Volume 147,902
Shares Issued 189.93m
Market Cap £14.56m
Beta 1.46
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.90% above the market average16.90% above the market average16.90% above the market average16.90% above the market average16.90% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
93.26% below the market average93.26% below the market average93.26% below the market average93.26% below the market average93.26% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average
Income Not Available
Growth
34.35% below the market average34.35% below the market average34.35% below the market average34.35% below the market average34.35% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average

RENX Dividends

No dividends found

Trades for 20-Nov-2024

Time Volume / Share Price
10:54 43 @ 7.50p
10:48 10,357 @ 7.50p
10:12 25,000 @ 7.50p
09:48 12,500 @ 7.50p
09:08 100,000 @ 7.55p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page